MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis

  1. Saman Hussain
  2. Carl N Wivagg
  3. Piotr Szwedziak
  4. Felix Wong
  5. Kaitlin Schaefer
  6. Thierry Izoré
  7. Lars D Renner
  8. Matthew J Holmes
  9. Yingjie Sun
  10. Alexandre W Bisson-Filho
  11. Suzanne Walker
  12. Ariel Amir
  13. Jan Löwe
  14. Ethan C Garner  Is a corresponding author
  1. Harvard University, United States
  2. MRC Laboratory of Molecular Biology, United Kingdom
  3. Harvard John A. Paulson School of Engineering and Applied Sciences, United States
  4. Leibniz Institute of Polymer Research, Germany

Abstract

MreB is essential for rod shape in many bacteria. Membrane-associated MreB filaments move around the rod circumference, helping to insert cell wall in the radial direction to reinforce rod shape. To understand how oriented MreB motion arises, we altered the shape of Bacillus subtilis. MreB motion is isotropic in round cells, and orientation is restored when rod shape is externally imposed. Stationary filaments orient within protoplasts, and purified MreB tubulates liposomes in vitro, orienting within tubes. Together, this demonstrates MreB orients along the greatest principal membrane curvature, a conclusion supported with biophysical modeling. We observed that spherical cells regenerate into rods in a local, self-reinforcing manner: rapidly propagating rods emerge from small bulges, exhibiting oriented MreB motion. We propose that the coupling of MreB filament alignment to shape-reinforcing peptidoglycan synthesis creates a locally-acting, self-organizing mechanism allowing the rapid establishment and stable maintenance of emergent rod shape.

Article and author information

Author details

  1. Saman Hussain

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Carl N Wivagg

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Piotr Szwedziak

    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5766-0873
  4. Felix Wong

    Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2309-8835
  5. Kaitlin Schaefer

    Department of Microbiology and Immunology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Thierry Izoré

    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Lars D Renner

    Leibniz Institute of Polymer Research, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthew J Holmes

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Yingjie Sun

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Alexandre W Bisson-Filho

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Suzanne Walker

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Ariel Amir

    Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2611-0139
  13. Jan Löwe

    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5218-6615
  14. Ethan C Garner

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    For correspondence
    egarner@g.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0141-3555

Funding

National Institutes of Health (DP2AI117923-01)

  • Ethan C Garner

Volkswagen Foundation

  • Lars D Renner
  • Ariel Amir
  • Ethan C Garner

Wellcome (095514/Z/11/Z)

  • Jan Löwe

National Science Foundation (GFRP)

  • Felix Wong

Medical Research Council (U105184326)

  • Jan Löwe

Howard Hughes Medical Institute (International Student Research Fellow)

  • Saman Hussain

National Institutes of Health (R01 GM076710)

  • Suzanne Walker

Searle Scholar Fellowship

  • Ethan C Garner

Alfred P. Sloan Foundation

  • Ariel Amir

Smith Family Award

  • Ethan C Garner

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Hussain et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,550
    views
  • 1,077
    downloads
  • 194
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Saman Hussain
  2. Carl N Wivagg
  3. Piotr Szwedziak
  4. Felix Wong
  5. Kaitlin Schaefer
  6. Thierry Izoré
  7. Lars D Renner
  8. Matthew J Holmes
  9. Yingjie Sun
  10. Alexandre W Bisson-Filho
  11. Suzanne Walker
  12. Ariel Amir
  13. Jan Löwe
  14. Ethan C Garner
(2018)
MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis
eLife 7:e32471.
https://doi.org/10.7554/eLife.32471

Share this article

https://doi.org/10.7554/eLife.32471

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Malika Hale, Kennidy K Takehara ... Marion Pepper
    Research Article

    Pseudomonas aeruginosa (PA) is an opportunistic, frequently multidrug-resistant pathogen that can cause severe infections in hospitalized patients. Antibodies against the PA virulence factor, PcrV, protect from death and disease in a variety of animal models. However, clinical trials of PcrV-binding antibody-based products have thus far failed to demonstrate benefit. Prior candidates were derivations of antibodies identified using protein-immunized animal systems and required extensive engineering to optimize binding and/or reduce immunogenicity. Of note, PA infections are common in people with cystic fibrosis (pwCF), who are generally believed to mount normal adaptive immune responses. Here, we utilized a tetramer reagent to detect and isolate PcrV-specific B cells in pwCF and, via single-cell sorting and paired-chain sequencing, identified the B cell receptor (BCR) variable region sequences that confer PcrV-specificity. We derived multiple high affinity anti-PcrV monoclonal antibodies (mAbs) from PcrV-specific B cells across three donors, including mAbs that exhibit potent anti-PA activity in a murine pneumonia model. This robust strategy for mAb discovery expands what is known about PA-specific B cells in pwCF and yields novel mAbs with potential for future clinical use.

    1. Microbiology and Infectious Disease
    Ziyu Wen, Pingchao Li ... Caijun Sun
    Research Article

    The persistence of latent viral reservoirs remains the major obstacle to eradicating human immunodeficiency virus (HIV). We herein found that ICP34.5 can act as an antagonistic factor for the reactivation of HIV latency by herpes simplex virus type I (HSV-1), and thus recombinant HSV-1 with ICP34.5 deletion could more effectively reactivate HIV latency than its wild-type counterpart. Mechanistically, HSV-ΔICP34.5 promoted the phosphorylation of HSF1 by decreasing the recruitment of protein phosphatase 1 (PP1α), thus effectively binding to the HIV LTR to reactivate the latent reservoirs. In addition, HSV-ΔICP34.5 enhanced the phosphorylation of IKKα/β through the degradation of IκBα, leading to p65 accumulation in the nucleus to elicit NF-κB pathway-dependent reactivation of HIV latency. Then, we constructed the recombinant HSV-ΔICP34.5 expressing simian immunodeficiency virus (SIV) env, gag, or the fusion antigen sPD1-SIVgag as a therapeutic vaccine, aiming to achieve a functional cure by simultaneously reactivating viral latency and eliciting antigen-specific immune responses. Results showed that these constructs effectively elicited SIV-specific immune responses, reactivated SIV latency, and delayed viral rebound after the interruption of antiretroviral therapy (ART) in chronically SIV-infected rhesus macaques. Collectively, these findings provide insights into the rational design of HSV-vectored therapeutic strategies for pursuing an HIV functional cure.